Determination of Rituximab Dose According to Immunologic Risk in ABO-Incompatible Kidney Transplantation

REFERENCES

• Ichimaru N, Takahara S. Japan’s experience with living-donor kidney transplantation across ABO barriers. Nature Clinical Practice Nephrology. 2008;4:682–692.
   PubMedGoogle Scholar
• Genberg H, Kumlien G, Wennberg L, Berg U, Tydn G. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: A 3-year follow-up. Transplantation. 2008;85:1745–1754.
   PubMed Web of Science ®Google Scholar
• Sonnenday CJ, Warren DS, Cooper M, . Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant. 2004;4:1315–1322.
   PubMed Web of Science ®Google Scholar
• Gloor JM, Stegall MD. O incompatible kidney transplantation. Current opinion in nephrology and hypertension. 2007;16:529–534.
   PubMedGoogle Scholar
• Tyden G, Donauer J, Wadstrom J, . Implementation of a protocol for ABO-incompatible kidney transplantation: A three-center experience with 60 consecutive transplantations. Transplantation. 2007;83:1153–1155.
   PubMed Web of Science ®Google Scholar
• Fuchinoue S, Ishii Y, Sawada T, . The 5-year outcome of ABO-incompatible kidney transplantation with rituximab induction. Transplantation. 2011;91:853–857.
   PubMed Web of Science ®Google Scholar
• Chung BH, Lee JY, Kang SH, . Comparison of clinical outcome between high and low baseline anti-ABO antibody titers in ABO-incompatible kidney transplantation. Ren Fail. 2011;33:150–158.
   PubMed Web of Science ®Google Scholar
• Tobian AA, Shirey RS, Montgomery RA, Tisch DJ, Ness PM, King KE. Therapeutic plasma exchange reduces ABO titers to permit ABO-incompatible renal transplantation. Transfusion. 2009;49:1248–1254.
   PubMedGoogle Scholar
• Vieira CA, Agarwal A, Book BK, . Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics. Transplantation. 2004;77:542–548.
   PubMed Web of Science ®Google Scholar
• Toki D, Ishida H, Horita S, Setoguchi K, Yamaguchi Y, Tanabe K. Impact of low-dose rituximab on splenic B cells in ABO-incompatible renal transplant recipients. Transpl Int. 2009;22:447–454.
   PubMed Web of Science ®Google Scholar
• Shirakawa H, Ishida H, Shimizu T, . The low dose of rituximab in ABO-incompatible kidney transplantation without a splenectomy: A single-center experience. Clin Transplant. 2011;25:878–884.
   PubMedGoogle Scholar
• Schroder C, Azimzadeh AM, Wu G, Price JO, Atkinson JB, Pierson RN. Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys. Transpl Immunol. 2003;12:19–28.
   PubMed Web of Science ®Google Scholar
• Lawrence C, Galliford JW, Willicombe MK, . Antibody removal before ABO-incompatible renal transplantation: How much plasma exchange is therapeutic? Transplantation. 2011;92:1129–1133.
   Google Scholar
• Tobian AA, Shirey RS, Montgomery RA, . ABO antibody titer and risk of antibody-mediated rejection in ABO-incompatible renal transplantation. Am J Transplant. 2010;10:1247–1253.
   PubMed Web of Science ®Google Scholar
• Grim SA, Pham T, Thielke J, . Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients. Clin Transplant. 2007;21:628–632.
   PubMed Web of Science ®Google Scholar
• Aikawa A, Ohara T, Arai K, . Clinical outcome and accommodation in ABO incompatible kidney transplantation. Clin Transplant. 2004;135–142.
   Google Scholar
• Habicht A, Broker V, Blume C, . Increase of infectious complications in ABO-incompatible kidney transplant recipients a single centre experience. Nephrol Dial Transplant. 2011;26:4124–4131.
   PubMed Web of Science ®Google Scholar
• Choi BS, Shin MJ, Shin SJ, . Clinical significance of an early protocol biopsy in living-donor renal transplantation: Ten-year experience at a single center. Am J Transplant. 2005;5:1354–1360.
   PubMedGoogle Scholar
• Solez K, Colvin RB, Racusen LC, . Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant. 2008;8:753–760.
   PubMed Web of Science ®Google Scholar
• Setoguchi K, Ishida H, Shimmura H, . Analysis of renal transplant protocol biopsies in ABO-incompatible kidney transplantation. Am J Transplant. 2008;8:86–94.
   PubMedGoogle Scholar
• Haas M, Segev DL, Racusen LC, . C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts. J Am Soc Nephrol. 2009;20:197–204.
   PubMedGoogle Scholar
• Montgomery RA, Locke JE, King KE, . ABO incompatible renal transplantation: A paradigm ready for broad implementation. Transplantation. 2009;87:1246–1255.
   PubMed Web of Science ®Google Scholar